CONMED Corp CNMD 65.62
Health Care · NYSE · Data as of 2026-10-28
CONMED Corp (CNMD) has delivered +6.9% annualized revenue growth, n/a earnings growth, and +1.4% dividend growth over 10 years of data. Ranked #381 of 1968 stocks overall and #35 of 260 in the Health Care sector by Steady Score.
About CONMED Corp
Company Overview
CONMED develops medical devices used in surgery. Its products include electrosurgical systems, orthopedic instruments and implants, insufflation and smoke-management equipment, and devices for minimally invasive procedures. Surgeons and hospitals use them in sports medicine, general surgery, gynecology, gastroenterology and other specialties. The company sells capital equipment and procedure-specific disposable products worldwide.
Read more
Business Model & Revenue
Revenue comes from surgical disposables, implants, instruments and capital equipment. Installed generators and systems can create recurring demand for compatible handpieces, tubing and other consumables. Orthopedic Surgery and General Surgery group the portfolio. Procedure volumes, hospital budgets, product launches and physician adoption drive sales, while direct representatives and distributors provide training and account support.
Key Facts & Market Position
CONMED combines durable operating-room equipment with recurring products used per procedure. Clinical performance, surgeon familiarity and integration with existing systems influence purchasing. Medical-device regulation, sterile supply, quality controls and product liability are central, while acquisitions have broadened access to faster-growing minimally invasive applications.